Neurocrine Biosciences
NBIX
#1383
Rank
A$23.07 B
Marketcap
A$231.44
Share price
-0.77%
Change (1 day)
14.71%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Stock price history for Neurocrine Biosciences (NBIX)

Highest end of day price: A$234.03 AUD on 2025-12-05

Lowest end of day price: A$3.01 AUD on 2009-11-12

Stock price history of Neurocrine Biosciences from 1996 to 2025

Annual Stock Price Performance

Year Performance
2025 12.43%
2024 3.62%
2023 9.73%
2022 35.01%
2021-11.16%
2020-11.50%
2019 53.36%
2018-9.95%
2017 100.70%
2016-26.07%
2015 147.68%
2014 133.93%
2013 14.74%
2012-12.51%
2011 10.82%
2010 184.01%
2009-16.82%
2008-29.20%
2007-55.79%
2006-83.61%
2005 27.97%
2004-11.17%
2003 20.11%
2002-9.71%
2001 59.41%
2000 31.84%
1999 260.00%
1998-17.29%
1997-17.65%
1996-20.00%

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
A$244.97 1.23%๐Ÿ‡บ๐Ÿ‡ธ USA
A$57.79-0.70%๐Ÿ‡ฌ๐Ÿ‡ง UK
A$32.35 0.54%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1,500-0.09%๐Ÿ‡บ๐Ÿ‡ธ USA
A$334.81-0.29%๐Ÿ‡บ๐Ÿ‡ธ USA
A$38.71-0.19%๐Ÿ‡บ๐Ÿ‡ธ USA
A$125.22 2.30%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.02032-33.50%๐Ÿ‡บ๐Ÿ‡ธ USA